Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Grouzmann

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Journal of Neurochemistry|March 25, 2009
Regulation of catecholamine release and tyrosine hydroxylase in human adrenal chromaffin cells by interleukin-1beta: role of neuropeptide Y and nitric oxideJoana Rosmaninho-Salgado, Inês M Araújo, Ana Rita Alvaro, et al.
The Journal of Clinical Endocrinology and Metabolism|May 10, 2012
Monoamine oxidase A down-regulation contributes to high metanephrine concentration in pheochromocytomaEric Grouzmann, Maurice Matter, Stefan Bilz, et al.
Clinical Chemistry and Laboratory Medicine|May 19, 2009
Proficiency test of plasma free and total metanephrines: report from a study groupDilo Pillai, H Alec Ross, Jürgen Kratzsch, et al.
Journal of Neurochemistry|March 19, 2005
Up-regulation of neuropeptide Y levels and modulation of glutamate release through neuropeptide Y receptors in the hippocampus of kainate-induced epileptic ratsAna P Silva, Sara Xapelli, Paulo S Pinheiro, et al.
Plos One|May 7, 2015
Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?Eric Grouzmann, Oliver Tschopp, Frédéric Triponez, et al.
Journal of the Endocrine Society|September 19, 2019
Dipeptidyl Peptidase 4 Inhibition Increases Postprandial Norepinephrine via Substance P (NK1 Receptor) During RAAS InhibitionJessica R Wilson, Scott Jafarian Kerman, Scott A Hubers, et al.
The Journal of Biological Chemistry|July 22, 2009
Kinetic study of neuropeptide Y (NPY) proteolysis in blood and identification of NPY3-35: a new peptide generated by plasma kallikreinKarim Abid, Bertrand Rochat, Paul-Gerhard Lassahn, et al.
Frontiers in Endocrinology|December 19, 2022
Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertensionAnnick Mühlethaler-Mottet, Silvia Uccella, Deborah Marchiori, et al.
Plos One|May 11, 2012
Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory studyCédric M Hysek, Linda D Simmler, Valentina G Nicola, et al.
Hypertension (Dallas, Tex. : 1979)|July 11, 2018
DPP (Dipeptidyl Peptidase)-4 Inhibition Potentiates the Vasoconstrictor Response to NPY (Neuropeptide Y) in Humans During Renin-Angiotensin-Aldosterone System InhibitionScott A Hubers, Jessica R Wilson, Chang Yu, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Journal of Neurochemistry|March 25, 2009
Regulation of catecholamine release and tyrosine hydroxylase in human adrenal chromaffin cells by interleukin-1beta: role of neuropeptide Y and nitric oxideJoana Rosmaninho-Salgado, Inês M Araújo, Ana Rita Alvaro, et al.
The Journal of Clinical Endocrinology and Metabolism|May 10, 2012
Monoamine oxidase A down-regulation contributes to high metanephrine concentration in pheochromocytomaEric Grouzmann, Maurice Matter, Stefan Bilz, et al.
Clinical Chemistry and Laboratory Medicine|May 19, 2009
Proficiency test of plasma free and total metanephrines: report from a study groupDilo Pillai, H Alec Ross, Jürgen Kratzsch, et al.
Journal of Neurochemistry|March 19, 2005
Up-regulation of neuropeptide Y levels and modulation of glutamate release through neuropeptide Y receptors in the hippocampus of kainate-induced epileptic ratsAna P Silva, Sara Xapelli, Paulo S Pinheiro, et al.
Plos One|May 7, 2015
Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?Eric Grouzmann, Oliver Tschopp, Frédéric Triponez, et al.
Journal of the Endocrine Society|September 19, 2019
Dipeptidyl Peptidase 4 Inhibition Increases Postprandial Norepinephrine via Substance P (NK1 Receptor) During RAAS InhibitionJessica R Wilson, Scott Jafarian Kerman, Scott A Hubers, et al.
The Journal of Biological Chemistry|July 22, 2009
Kinetic study of neuropeptide Y (NPY) proteolysis in blood and identification of NPY3-35: a new peptide generated by plasma kallikreinKarim Abid, Bertrand Rochat, Paul-Gerhard Lassahn, et al.
Frontiers in Endocrinology|December 19, 2022
Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertensionAnnick Mühlethaler-Mottet, Silvia Uccella, Deborah Marchiori, et al.
Plos One|May 11, 2012
Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory studyCédric M Hysek, Linda D Simmler, Valentina G Nicola, et al.
Hypertension (Dallas, Tex. : 1979)|July 11, 2018
DPP (Dipeptidyl Peptidase)-4 Inhibition Potentiates the Vasoconstrictor Response to NPY (Neuropeptide Y) in Humans During Renin-Angiotensin-Aldosterone System InhibitionScott A Hubers, Jessica R Wilson, Chang Yu, et al.
Pageof 11